Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11945799 4-ethynylpyridine derivatives useful as GCN2 inhibitors

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Matthew Fuchter0

Gavin Whitlock0

Date of Patent

April 2, 2024

0

Patent Application Number

181917720

Date Filed

March 28, 2023

0

Patent Citations

US Patent 11046699 Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses

0

US Patent 10793563 GCN2 inhibitors and uses thereof

0

US Patent 10988477 GCN2 inhibitors and uses thereof

0

US Patent 7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor

0

US Patent 7595332 Amides that inhibit vanilloid receptor subtype 1 (VR1)

0

US Patent 8546413 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors

0

US Patent 8969366 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors

0

US Patent 9409914 Triazolo[4,5-d]pyrimidine derivatives

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11945799 4-ethynylpyridine derivatives useful as GCN2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool